Dojolvi is usually taken orally in the form of a liquid. The general instructions for use are as follows:
Measure the dose carefully using the provided measuring device.
Take it with food to help with absorption.
Divide the dose as prescribed by your healthcare provider, typically into two doses per day.
Shake the bottle well before use to ensure the medication is evenly mixed.
Store the medication as directed, usually at room temperature, and away from excessive heat or moisture.
If a dose is missed, take it as soon as possible unless it’s close to the time for the next dose. Do not take two doses at once to make up for a missed dose.
Dojolvi works by supplying the body with triheptanoin, a medium-chain triglyceride (MCT) that is metabolized into smaller molecules called heptanoic acid. Unlike long-chain fatty acids, which require complex enzymatic breakdown for energy production, triheptanoin is quickly processed by the liver into heptanoic acid. This molecule can then be used by muscles and other tissues to produce energy.
Since the body can’t properly use long-chain fatty acids in patients with LC-FAOD, triheptanoin offers an alternative energy source that bypasses the metabolic block. By providing this readily available energy, Dojolvi helps prevent dangerous drops in blood sugar and supports the body’s metabolism, particularly during periods of fasting or illness when energy demands are higher.
This action helps reduce the risks associated with LC-FAOD, such as fatigue, hypoglycemia, and muscle weakness.
While Dojolvi can provide significant benefits, like all medications, it may cause side effects. Some common side effects of Dojolvi include:
Gastrointestinal issues: Some individuals may experience nausea, vomiting, or diarrhea, especially when starting treatment or adjusting the dosage.
Fatigue or drowsiness: Some people may feel unusually tired, particularly when their body is adjusting to the medication.
Headache: Headaches may occur as the body adjusts to the treatment.
Weight gain: Due to the calorie content in Dojolvi, some individuals may experience mild weight gain.
If any side effects become severe or persistent, it’s important to contact a healthcare provider for guidance.
There are several important warnings and precautions to consider when using Dojolvi:
Liver Function: Dojolvi is metabolized in the liver. People with pre-existing liver conditions may require careful monitoring during treatment.
Dietary Considerations: It is important to maintain a balanced diet while using Dojolvi, as the medication is part of a broader treatment plan that often includes dietary adjustments.
Pregnancy and Breastfeeding: The safety of Dojolvi during pregnancy and breastfeeding has not been fully established. Consult a healthcare provider before using Dojolvi if you are pregnant, planning to become pregnant, or breastfeeding.
- Long-Term Use: As Dojolvi is typically used for long-term management of LC-FAOD, patients should work closely with their healthcare providers to ensure appropriate dosing and monitoring over time.
Certain medications or conditions may affect how Dojolvi works or increase the risk of side effects. Some possible interactions include:
Other fat-soluble medications: Since Dojolvi is a type of fat, it may affect the absorption or metabolism of other fat-soluble medications, such as certain vitamins or drugs.
Liver function: Dojolvi is metabolized by the liver, so individuals with liver conditions may require closer monitoring or dose adjustments.
As with any medication, it is important to inform your healthcare provider about all medications, supplements, and underlying health conditions before starting Dojolvi.
The dosage of Dojolvi is generally determined based on the patient’s body weight and individual needs. The typical starting dose is:
Your healthcare provider will adjust the dosage based on your response to treatment. It’s crucial to follow their instructions and attend regular follow-up appointments to monitor your condition.
Dojolvi is a prescription-only medication. This means it must be prescribed by a healthcare provider, who will assess your condition and determine whether Dojolvi is appropriate for you. It’s essential that patients taking Dojolvi are closely monitored to ensure the medication is effective and to minimize any potential risks or side effects.
Patients should not self-medicate or adjust their dosage without consulting their healthcare provider.